Source link : https://newshealth.biz/health-news/ozempic-improves-glycemic-control-cuts-weight-in-schizophrenia-patients/

(MedPage Today) — Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose schizophrenia was being treated with the second-generation antipsychotics clozapine or olanzapine. The… Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/118814 Author : Publish date : 2025-12-03 20:50:00 Copyright for syndicated content belongs to the linked Source.

The post Ozempic Improves Glycemic Control, Cuts Weight in Schizophrenia Patients first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-03 20:50:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678